Evidence map›Paper›PMID 36510218›Full record

ArticleTrials2022

Effect of Tai Chi versus aerobic exercise on blood pressure in prehypertension patients (TCOBPP): a study protocol for a 12-month single-blind randomized controlled trial.

Xinye Li, Yonghong Gao, Min Wu, Dawei Wei, Xingjiang Xiong, Yan Yang, Yuchen Jiang, Xiandu Pan, Ran Zhao, Fan Yang and 7 more

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Xinye Li *Beijing University of Chinese Medicine, Beijing, 100029, China.
Yonghong Gao *Key Laboratory of Chinese Internal Medicine of the Ministry of Education, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100029, China.
Min Wu *Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
Dawei Wei *Beijing University of Chinese Medicine, Beijing, 100029, China.
Xingjiang Xiong *Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
Yan Yang *Beijing University of Chinese Medicine, Beijing, 100029, China.
Yuchen JiangGuang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
Xiandu PanBeijing University of Chinese Medicine, Beijing, 100029, China.
Ran ZhaoBeijing University of Chinese Medicine, Beijing, 100029, China.
Fan YangGuang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
Jiahao SunBeijing University of Chinese Medicine, Beijing, 100029, China.
Shengjie YangGuang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
Li TianBeijing University of Chinese Medicine, Beijing, 100029, China.
Linqiang BanBeijing University of Chinese Medicine, Beijing, 100029, China.
Xingye LiBeijing University of Chinese Medicine, Beijing, 100029, China.
Peifen ChangDongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100029, China. 13661022016@163.com.
Yanwei XingGuang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China. xingyanwei12345@163.com.
Beijing University of Chinese Medicine · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNDongzhimen Hospital Affiliated to Beijing University of Chinese Medicine · CNGuang’anmen Hospital · CN

Funding

National Key R&D Program of China 2018YFC1704900 & 2018YFC1704901
6 · The paper itself

Abstract

backgroundCompared with optimal blood pressure (BP), the prehypertension increases the risk of incident hypertension, cardiovascular (CV) events, and death. Moderate intensity of regular physical activity can reduce BP. However, aerobic exercise has some limitations. As a safe, low-impact, enjoyable, and inexpensive form of exercise that requires minimal equipment and space, Tai Chi is expected as a viable alternative to aerobic exercise. The study aimed to assess the effect of Tai Chi intervention program, compared with aerobic exercise, on the BP in prehypertension patients.

methodsThis study is a 12-month, two-center, single-blind, parallel, randomized controlled trial. Three hundred forty-two patients with prehypertension [with a systolic blood pressure (SBP) in the range of 120 mmHg to 139 mmHg and/or a diastolic blood pressure (DBP) in the range of 80 mmHg to 89 mmHg] are randomized to one of two intervention groups in a 1:1 ratio: Tai Chi or aerobic exercise. BP monitoring methods of office blood pressure, ambulatory blood pressure monitoring (ABPM), and home blood pressure monitoring (HBPM) are used at the same time to detect BP in multiple dimensions. The primary outcome is the comparison of SBP change from baseline to 12 months in Tai Chi group and SBP change from baseline to 12 months in aerobic exercise group. The secondary endpoints are as following: (1) the comparison of DBP of office blood pressure change from baseline to 12 months between Tai Chi group and aerobic exercise group, (2) the comparison of BP and the variability of BP assessed through ABPM change from baseline to 12 months between Tai Chi group and aerobic exercise group, (3) the comparison of BP assessed through HBPM change from baseline to 12 months between Tai Chi group and aerobic exercise group. DISCUSSION: This will be the first randomized controlled trial to specifically study the benefits of Tai Chi on the blood pressure control in patients with prehypertension. The successful completion of this study will help to provide evidence for whether Tai Chi is more desirable than aerobic exercise.

trial registrationTrial registration number: Chinese Clinical Trial Registry, ChiCTR1900024368. Registered on 7 July 2019, http://www.chictr.org.cn/edit.aspx?pid=39478&htm=4.

Indexed as

HypertensionTai JiBlood PressureBlood Pressure Monitoring, AmbulatoryExerciseHumansRandomized Controlled Trials as TopicSingle-Blind MethodAerobic exerciseBlood pressurePrehypertensionTai Chi

Identifiers

PMID36510218
PMCPMC9743705
OpenAlexW4311577805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.